<DOC>
	<DOCNO>NCT01024465</DOCNO>
	<brief_summary>A prospective , non-randomized , open-label , multi-center study design implant twenty-six ( 26 ) CE-marked ReShapeâ„¢ Balloons twenty-six ( 26 ) patient body mass index ( BMI ) 30-40 ass effectiveness device . The RIB device use within labeled indication per instruction use . Enrolled patient follow seven month . The patient prescribe controlled diet , exercise counseling . One group 26 patient receive treatment follow : Placement , inflate 900 cc , remove 180 day , follow-up 30 day post removal ( endoscopic video capture placement removal require ) .</brief_summary>
	<brief_title>ReShape Intragastric Balloon Treatment Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>The patient male female age 20 60 year age . The patient present Body Mass Index ( BMI ) 3040 kg/m2 . The patient geographically stable willing return implant center followup visit . The patient adequately informed risk requirement consent his/her participation post market clinical study . The patient present 20 year &gt; Age &gt; 60 year . The patient progressive disease , Investigator 's experience produce unacceptable increase risk patient , result life expectancy le 12 month . The patient pregnant lactate female . The patient present 30 kg/m2 &gt; BMI &gt; 40 kg/m2 . The patient previous abdominal surgery . The patient digestive tract disorder active peptic ulcer , bleed disorder , esophageal varix , Crohn 's disease . The patient present psychiatric disorder . The patient participate concomitant research study investigational product would interfere study . The patient inability return followup assessment . The patient alcohol drug abuser .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>obesity</keyword>
	<keyword>intragastric balloon</keyword>
</DOC>